CoreCivic — Third Quarter 2026 Earnings Summary

CoreCivic reported third-quarter 2026 net income of $1.34 billion, driven primarily by a $1.77 billion gain from selling four detention facilities to the federal government. The company utilized proceeds from these sales to repay over $700 million in debt and executed a $500 million accelerated share repurchase agreement, reducing its leverage ratio to 0.1 times Adjusted EBITDA. Adjusted diluted earnings per share for the quarter reached $0.49, reflecting increased occupancy rates to 84.0% and the inclusion of the newly acquired Clinical Solutions Pharmacy. Additionally, the board expanded its share repurchase authorization by an additional $500 million, bringing the total program capacity to $1.7 billion.